Development of an international core domain set for medium, large and giant congenital melanocytic naevi as a first step towards a core outcome set for clinical practice and research
Abstract
Medium, large and giant congenital melanocytic naevi (CMN) can impose a psychosocial burden on patients and families, and are associated with increased risk of developing melanoma or neurological symptoms. Lack of consensus on what outcomes to measure makes it difficult to advise patients and families about treatment and to set up best practice for CMN.
Fichier principal
Manuscript CMN_revision_provisional acceptance-.pdf (847.51 Ko)
Télécharger le fichier
Origin : Files produced by the author(s)